Screener
Eton Pharmaceuticals, Inc. ETON Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | For the three months ended / March 31, 2026 | For the three months ended / March 31, 2025 |
|---|---|---|
| Other expense: | ||
| Interest and other expense, net | (840) | (1,028) |
| Income (loss) before income tax expense | 1,574 | (1,498) |
| Income tax expense | 20 | 74 |
| Net income (loss) | $1,554 | $(1,572) |
| Net income (loss) per share, basic | $0.06 | $(0.06) |
| Weighted average number of common shares outstanding, basic | 27,285 | 26,886 |
| Net income (loss) per share, diluted | $0.05 | $(0.06) |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s income tax?
- Eton Pharmaceuticals, Inc. (ETON) reported income tax of $20K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s income tax changed year-over-year?
- Eton Pharmaceuticals, Inc.'s income tax decreased by 73.0% year-over-year, from $74K to $20K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Eton Pharmaceuticals, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude